Saturday, 23 March 2019
Latest news
Main » Latest Analysts Research Reports About Gilead Sciences, Inc. (GILD), Constellium NV (CSTM)

Latest Analysts Research Reports About Gilead Sciences, Inc. (GILD), Constellium NV (CSTM)

14 September 2017

The stock of Brooks Automation, Inc (NASDAQ:BRKS) has "Buy" rating given on Thursday, August 3 by B. Riley & Co. Shares for $100,112 were bought by Conner Carlin G. Barpoulis Sarah Morrison had sold 1,470 shares worth $46,232 on Thursday, June 1. Buckingham Asset Ltd Liability Co has 6,090 shares. The fund held 35,585 stocks of the biopharmaceutical firms shares after disposing 3,905 shares through out the quarter. Dynegy Inc New Del (NYSE:DYN) was raised too. Park National Corp OH increased its position in Gilead Sciences by 1.5% during the second quarter.

Since January 1, 0001, it had 0 buys, and 1 insider sale for $34,918 activity. 31 funds opened positions while 49 raised stakes. Boston Family Office Ltd Company stated it has 12,807 shares or 0.14% of all its holdings.

First Foundation Advisors, which manages about $3.20 billion and $1.53 billion US Long portfolio, upped its stake in Retail Opportunity Investments (NASDAQ:ROIC) by 869,547 shares to 1.06M shares, valued at $22.34M in 2016Q4, according to the filing. New South Cap Mngmt invested 0.01% in Macquarie Infrastructure Corp (NYSE:MIC). Following the completion of the sale, the executive vice president now directly owns 102,988 shares of the company's stock, valued at approximately $7,318,327.28. The biopharmaceutical company reported $2.56 earnings per share for the quarter, topping the Zacks' consensus estimate of $2.11 by $0.45. Stockholders of record on Friday, September 15th will be given a dividend of $0.52 per share.

The top 5 institutional holders, in ascending order, are as follows: BLACKROCK INC. with 104.91 million shares, VANGUARD GROUP INC with 92.84 million shares, STATE STREET CORP with 58.12 million shares, BANK OF NEW YORK MELLON CORP with 30.88 million shares, and FMR LLC with 23.04 million shares. Cap Guardian Trust Communication invested 0% of its portfolio in iPass Inc. Royal National Bank Of Canada invested 0% in LendingClub Corp (NYSE:LC). The company's quarterly EPS surprised Wall Street by as much as 4% to the upside in its last earnings announcement, so investors should note this tendency when assessing consensus estimates. 700 were reported by Riverhead Cap Mgmt Ltd Liability Corporation. Tiaa Cref Invest Mgmt Lc holds 238,150 shares or 0.01% of its portfolio. Natl Pension Ser stated it has 926,786 shares or 0.45% of all its holdings. Therefore 86% are positive. Badger Meter had 12 analyst reports since July 21, 2015 according to SRatingsIntel. The rating was initiated by Raymond James with "Outperform" on Thursday, September 10. The rating was maintained by Piper Jaffray with "Overweight" on Friday, July 24. On Tuesday, July 25 the stock rating was maintained by Mizuho with "Buy". The research firm rates the sentiment of media coverage by analyzing more than twenty million news and blog sources. (NASDAQ:GILD) on Wednesday, June 1 with "Buy" rating. The company was downgraded on Friday, April 29 by Maxim Group. Buckingham Research initiated it with "Buy" rating and $80 target in Monday, October 19 report. On Wednesday, November 4 the stock rating was maintained by RBC Capital Markets with "Outperform". Its up 0.02, from 0.91 in 2016Q3. It improved, as 106 investors sold GILD shares while 656 reduced holdings. 950.84 million shares or 0.69% more from 944.29 million shares in 2016Q3 were reported. During the same quarter previous year, the firm posted $3.08 earnings per share. More interesting news about Gilead Sciences, Inc. Gilead Sciences, Inc. (GILD) has made its way to a 12-month gain of 7.18%.

Tekla Healthcare Investors is a non-diversified closed-end healthcare fund. Fiduciary Financial Services Of The Southwest Inc Tx, a Texas-based fund reported 32,586 shares. Prudential holds 0% or 20,920 shares in its portfolio. In the past 3-month period alone, shares of GILD have appreciated +19.08 - or +29.16%. 2,859,881 shares of the stock were exchanged. Argent Trust holds 0.49% or 15,354 shares. Envestnet Asset Mgmt has invested 0.1% of its portfolio in Gilead Sciences, Inc. Jefferies upgraded the shares of GILD in report on Tuesday, September 6 to "Buy" rating. North Carolina-based Jolley Asset Ltd Com has invested 2.4% in Gilead Sciences, Inc. (NASDAQ:GILD) for 4,752 shares. Virtu Financial Ltd accumulated 3,353 shares. (NASDAQ:GILD). Moreover, Renaissance Grp Inc has 0.98% invested in Gilead Sciences, Inc. The Veritable Lp holds 74,363 shares with $5.33M value, up from 69,384 last quarter.

Among 7 analysts covering MacQuarie Infrastructure (NYSE:MIC), 6 have Buy rating, 0 Sell and 1 Hold. Therefore 63% are positive. Salem Invest Counselors has invested 0.84% in Gilead Sciences, Inc. (NASDAQ:GILD) rating on Tuesday, July 25. On Thursday, February 11 the stock rating was initiated by Oppenheimer with "Outperform". The firm earned "Buy" rating on Thursday, September 22 by Berenberg. The firm earned "Buy" rating on Wednesday, October 12 by Citigroup. The company was upgraded on Wednesday, November 4 by Credit Suisse. The company was downgraded on Wednesday, February 8 by Citigroup. The rating was maintained by William Blair with "Buy" on Wednesday, June 14.

Since March 30, 2017, it had 0 insider purchases, and 7 selling transactions for $16.39 million activity. As per Thursday, August 31, the company rating was upgraded by Argus Research. MARTIN JOHN C sold $4.78M worth of stock or 73,333 shares. Alton Gregg H had sold 5,000 shares worth $325,114.

Latest Analysts Research Reports About Gilead Sciences, Inc. (GILD), Constellium NV (CSTM)